386 results on '"Alemozaffar, Mehrdad"'
Search Results
2. Robotic Repair of Ureteroenteric Stricture Following Radical Cystectomy: A Multi-Institutional Experience
3. MP01-12 ACCURACY OF FDG-PET SCAN IN PRIMARY TESTICULAR SEMINOMA: ANALYSIS FROM SEMS TRIAL
4. Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma
5. DIAGNOSTIC DILEMMAS IN PROSTATIC STROMAL-INVASIVE UCC WITH VARIANT HISTOLOGY
6. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases
7. Avoiding the Need for Bowel Anastomosis during Pelvic Exenteration—Urinary Sigmoid or Descending Colon Conduit—Short and Long Term Complications
8. Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy
9. Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis
10. Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy
11. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
12. Prediction of Erectile Function Following Treatment for Prostate Cancer
13. A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
14. Patient Frailty and Discharge Disposition Following Radical Cystectomy
15. Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology
16. Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States
17. Palliative care use among bladder cancer patients treated with radical cystectomy
18. Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer
19. MP33-18 SURGICAL AND ONCOLOGIC OUTCOMES OF SURGERY IN EARLY METASTATIC SEMINOMA: MULTI-INSTITUTIONAL RETROSPECTIVE STUDY
20. Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
21. Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
22. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
23. Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.
24. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
25. C-reactive protein in urologic cancers
26. Surgery for high-risk prostate cancer and metastatic prostate cancer
27. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease
28. Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer
29. Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy
30. Editorial Commentary
31. The role of adjuvant radiotherapy in pathologically lymph node‐positive prostate cancer
32. Stepwise Description and Outcomes of Bladder Neck Sparing During Robot-Assisted Laparoscopic Radical Prostatectomy
33. PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL
34. MP56-01 RENAL FUNCTIONAL CHANGES AFTER CYSTECTOMY: WHO IMPROVES AND WHO DOES NOT?
35. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial
36. Athermal Division and Selective Suture Ligation of the Dorsal Vein Complex During Robot-Assisted Laparoscopic Radical Prostatectomy: Description of Technique and Outcomes
37. EXTERNAL VALIDATION OF PREOPERATIVE AST/ALT (DE-RITIS) RATIO AS A PROGNOSTIC INDICATOR IN LOCALIZED AND METASTATIC RENAL CELL CARCINOMA: MP73-18
38. UROLOGIST USE OF CYSTOSCOPY FOR PATIENTS PRESENTING WITH HEMATURIA: MP37-16
39. DELAYED TREATMENT OF HIGH-RISK PROSTATE CANCER PATIENTS: IMPACT OF SOCIOECONOMIC BARRIERS AND USE OF ADVANCED TECHNOLOGIES: MP37-06
40. FRAIL PATIENTS ARE LESS LIKELY TO BE DISCHARGED TO HOME AFTER CYSTECTOMY: MP06-12
41. ROBOTIC RADICAL CYSTECTOMY WITH INTRA-CORPOREAL NEOBLADDER URINARY DIVERSION: V1-09
42. The importance of surgical margins in renal cell and urothelial carcinomas
43. Randomized Controlled Trial of Barbed Polyglyconate Versus Polyglactin Suture for Robot-Assisted Laparoscopic Prostatectomy Anastomosis: Technique and Outcomes
44. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial
45. V8-06 BLUE LIGHT CYSTOSCOPY: THE USC EXPERIENCE
46. MP44-08 PRE-OPERATIVE MODIFIED GLASGOW PROGNOSTIC SCORE AS AN INDEPENDENT PROGNOSIS FACTOR IN A LARGE U.S. POPULATION
47. MP35-14 COMMONLY-USED COST-EFFECTIVE PRE-OPERATIVE INFLAMMATORY MARKERS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
48. Robotic partial nephrectomy versus laparoscopic partial nephrectomy: a single laparoscopic trained surgeon’s experience in the development of a robotic partial nephrectomy program
49. PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL
50. BLUE LIGHT CYSTOSCOPY: INITIAL USC EXPERIENCE: V10-01
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.